ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer
ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer
Recruiting · NCT03294889 · Registry updated 2020-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 / Phase 2 | 2020-05-14 | NCT03294889 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Humanitas Hospital, Italy | 10 |
| Kantonsspital Graubünden | 4 |
| University Hospital, Geneva | 108 |
| University of Zurich | 188 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Hospital of Geneva | Geneva | Switzerland | 4 |